Skip to main content
Journal ArticleOPEN ACCESS

Emergence of overt myeloma in a patient with chronic lymphocytic leukemia on ibrutinib therapy

Clinical Case Reports (2020) 8(9) 1797-1801
DOI: 10.1002/ccr3.3019
0Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Ibrutinib is approved for chronic lymphocytic leukemia (CLL). However, its role in the treatment of multiple myeloma (MM) is not clear and is under investigation. We report a case of CLL that developed MM while on therapy with ibrutinib indicating that this drug may not be active against MM.

Author supplied keywords

Cite

CITATION STYLE

APA

Al-Katib, A. M., Gaith, H., Sano, D., Al-Katib, S., Bonnett, M., & Kafri, Z. (2020). Emergence of overt myeloma in a patient with chronic lymphocytic leukemia on ibrutinib therapy. Clinical Case Reports, 8(9), 1797–1801. https://doi.org/10.1002/ccr3.3019

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free